| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |